Built by a former cannabis regulator, Policy, Decoded helps operators read the policy terrain before it shifts beneath their feet.
Today's edition is sponsored by Masterworks. Their support keeps these briefings free and focused on what actually matters.
Virginia's legislature reconvenes today to decide whether to accept a governor's rewrite that dismantles the retail framework they spent years negotiating. Colorado's Marijuana Enforcement Division just published a bulletin admitting, in so many words, that its licensed supply chain has been laundering hemp-derived THC through Metrc. Delaware denied 23 social equity licenses after an Arizona consulting firm captured the control rights before the lottery even closed. Connecticut threatened a cultivator's license over lab results the cultivator says the state cannot scientifically defend. A Boston dispensary's former employee is suing for wages after the company's accounts were frozen. Two likely 2028 presidential candidates spent 4/20 publicly touting their cannabis records. Look at any handoff in the market today and ask who is actually on the hook.
🚨 Tomorrow's reconvened vote on Spanberger's rewrite
🎟️ Delaware catches an Arizona consulting scheme
💸 Pritzker and Beshear spend 4/20 on their records
Man's capacity for justice makes democracy possible; but man's inclination to injustice makes democracy necessary.
Investors see ANOTHER return from Masterworks (!!!!)
That’s 5 sales in 4 months. 28 all time. And the performance?
14.6%, 17.6%, and 17.8%, net annualized returns on sold works held longer than one year (See all 28 at Masterworks.com).
It’s not from stocks, private equity, or real estate… it’s from contemporary and post war art. Crazy, right?
With Masterworks, you don’t need to be a BILLIONAIRE to invest in multi-million dollar art anymore.
Historically, the segment overall has had attractive appreciation and low correlation to stocks.*
Masterworks targets works featuring legends like Banksy, Basquiat, and Picasso, identifying what they believe to have significant long-term appreciation potential, not just at the artist level but at the level of individual artworks.
As one of the largest players in the art market, with $1.3 billion invested over 500 artworks, they pass critical advantages through to their 70,000+ members to add art to their portfolios strategically.
Looking to diversify your investments in 2026?
*According to Masterworks data. Investing involves risk. Past performance is not indicative of future returns. See important Reg A disclosures at masterworks.com/cd.

Policy intelligence, marked up.
Virginia's General Assembly reconvenes today to decide whether to accept Gov. Abigail Spanberger's substitute of the state's adult-use retail bill. Sen. Lashrecse Aird and Del. Paul Krizek are urging colleagues to reject it, even if that kills the legislation for the year. The rewrite moves the launch from January 1 to July 1, 2027; cuts the dispensary cap from 350 to 200 through January 2029; holds the state tax at 6 percent but raises it to 8 percent in 2029; drops possession from 2.5 ounces to 2; strips dedicated revenue streams for early childhood programs and cannabis equity reinvestment; and restores criminal penalties for public consumption. Democrats hold a 21-19 Senate margin, short of the two-thirds needed for an override. Spanberger came to the Governor's Mansion from Congress and campaigned on getting adult-use sales off the ground, so this is also her first high-stakes negotiation with the legislature as chief executive. The sponsors appear to be testing whether she will sign the bill she inherited if they send it back intact, or veto and force the fight into 2027. Virginia has been possession-legal without retail sales for more than five years. Whether that limbo ends today depends on which side blinks first. (Marijuana Moment)
Jim Hamilton, owner of Grass Roots Marijuana, contacted Maine's Office of Cannabis Policy about a state rule requiring remediated marijuana to carry a label stating "contents have been treated" in no less than 6-point font. The office told him in writing that it is not currently enforcing that rule and plans to issue guidance in the future. The labeling dispute is the visible edge of a harder policy question. Remediation is the process used when testing finds bacteria, mold, yeast, or other microorganisms on cannabis, and it is contested on its own terms. It severely impacts water activity in the plant, rendering flower harsh, dry, brittle, and wrecks the best part - terpenes! It also lightens the bud, so you’re radiating away your profit, too. University of Colorado-Boulder research associate Tess Eidem told WGME that remediation reduces microbial viability without eliminating presence, meaning dead and dormant microorganisms can remain on product. Regulators, labs, and operators are still working through whether remediation should be permitted at all, what disclosure should look like if it is, and how to balance waste reduction against consumer protection. In other words, we’re still building standards. None of those questions have clean answers. OCP's signal that guidance is coming suggests the agency is working through the same set of questions the broader market has not yet resolved. Hamilton's frustration is real, and so is the complexity of getting the policy right. Worth watching what guidance the office issues, and when. (WGME / CBS13)
💰 A Blank Rome conversation with three cannabis lenders lands on a useful point operators should internalize: rescheduling matters, but it matters as a gradual reshaping of capital markets rather than a liquidity event. Alex Mazza at Chicago Atlantic Group expects stronger borrowers and rising demand for capital without a matching jump in supply, since new lenders will not stand up cannabis programs overnight. Michelle Haughton and Bobby Boyda at Needham Bank see product evolution over time, toward revolving lines, equipment loans, and eventually credit cards. Both agree compliance burdens do not ease. FinCEN stays stringent without SAFE or SAFER, state licensing holds, and past-due tax liabilities do not vanish. Evolution, not revolution. (National Law Review / Blank Rome)
Delaware's Office of the Marijuana Commissioner denied 23 conditional licenses tied to 19 social equity applicants after determining that an Arizona consulting firm, Cannabis Business Advisors, had structured contracts designed to take control of the licenses before any business opened. Commissioner Joshua Sanderlin described the fee structures as "unreasonably excessive," making it "inevitable" that the consultant would end up owning the license. The firm, headed by investor Michael Halow, ran a door-to-door campaign in neighborhoods with high marijuana conviction rates, routed state correspondence through its own staff, and has pursued the same model in Missouri and Arizona. Jacqueline Lacy of Georgetown thought the postcard she received in 2024 was from the state. Delaware received 1,271 applications for 125 licenses, and the firm's volume inside that pool is still unclear - the former head of the Delaware Cannabis Industry Association calls this flooding the lottery. The applicants in this scheme are victims. Many of them qualified for social equity because of prior marijuana convictions or residence in disproportionately impacted areas, which is exactly the profile these contracts were designed to prey on. Regulators now have to figure out how to hold harmless the people who signed in good faith while making this a teachable moment for the next state running a lottery. And Halow? Targeting people by zip code and criminal record, then writing $1 million breakup fees into the paperwork, is a dick move dressed up as consulting. (WHYY)
Gov. JB Pritzker and the Illinois Department of Commerce and Economic Opportunity announced $31.8 million in forgivable loans to 95 social equity licensees yesterday. The 4/20 timing was not incidental. Round III is the first to reach all major license types - craft growers, infusers, transporters, and dispensaries - and brings program deployment above $55 million. Terms: 4 percent interest after an 18-month grace period, principal fully forgivable with documentation of eligible expenses. Illinois has spent years demonstrating that winning a social equity license and opening a business are separate problems; direct forgivable loans close the financing gap without resolving every structural barrier. Pritzker is widely considered a potential 2028 Democratic presidential candidate, and spending 4/20 on a public equity check is the kind of record-building move that suggests he plans to run on it. (Chicago Tribune)
Gov. Andy Beshear cut the ribbon on a Tier One medical cultivator in Providence yesterday, the kind of visible buildout new medical states need to show their programs have moved from licensing exercise to operating supply chain. Beshear is also widely considered a 2028 Democratic presidential candidate. With Pritzker spending the same 4/20 on a $31.8 million equity check in Illinois, the two Democratic governors most often floated for a national run both used cannabis policy for public positioning on the same day. The question going forward is whether Beshear touts the Kentucky medical rollout as he tests the waters, or puts distance between himself and it. Watching how often cannabis comes up in his national appearances will tell us a lot about which direction he thinks the issue cuts in a primary. (14 News)
Connecticut regulators are moving to suspend or revoke Affinity Grow's license, alleging the cultivator mislabeled failed batches to circumvent authorization processes and failed to test dozens of gummy products for residual solvents. Affinity president Rino Ferrarese - who has tussled with the agency before - argues the dispute rests on flawed chromium testing protocols, says no product from the challenged batches reached consumers, and says affected material was quarantined. The allegations now move through an administrative process that should include evidence, cross-examination, and a factual record. Let it play out. Operators and regulators alike are better served by a clean adjudication than by public positioning. (CT Insider)
🧪 Colorado lawmakers are considering SB 161, which would move cannabis lab oversight from the MED to the Colorado Department of Public Health and Environment, require regulators to collect samples directly from dispensary shelves, and make results public. The state has issued 10 recalls in four months. Whether bureaucratic reshuffling is the right tool is a legitimate policy question, but the underlying goals - better testing, reduced risk of fraud, public confidence in what is on the label - deserve serious discussion. (MJBizDaily)
New Jersey's new hemp definitions took effect April 13th, treating most higher-THC hemp products as cannabis while allowing liquor stores to continue selling qualifying hemp beverages through November 13th under tighter potency and testing rules. Read this as preparation for federal alignment rather than defiance of it. November 13th comes one day after the federal hemp rewrite takes effect, and the state is signaling that it plans to fall in line with Washington while acknowledging that consumer demand for low-dose hemp beverages is real and worth serving through a controlled channel in the interim. The hierarchy matters: beverages get a regulated off-ramp inside the three-tier system; broader convenience-store access to intoxicating hemp does not. Other states writing their November 12th playbooks are watching how New Jersey manages this window. (WineBusiness)
🍺 Generation NA, an Indiana non-alcoholic bottle shop owned by Rob Theodorow, sells hemp-derived THC and CBD beverages in a Lafayette market that existed because the 2018 Farm Bill created the legal space for it. Indiana SB 250 could close that space. Theodorow told lawmakers that 99 percent of his CBD and THC inventory and 70 percent of his overall sales would be affected if the bill's 0.4-milligram-per-container THC limit passes in current form. His business opened in 2022 under a legal framework that is now being rewritten around him. This is what the federal hemp transition looks like at ground level in a state that never legalized marijuana. (WLFI; Purdue Exponent)
Missouri Attorney General Catherine Hanaway's campaign against intoxicating hemp retailers has given the retailers an argument she did not intend to hand them. Store owners told the Missouri Independent they plan to keep selling until the new federal restrictions take effect November 12th, while challenging the state's reliance on testing evidence supplied by the Missouri Cannabis Trade Association, whose members compete directly with hemp sellers. When an attorney general bases enforcement on evidence gathered by an interested market faction, the state opens a second front on process fairness beyond the product question itself. (KCUR / Missouri Independent)
🌵 Texas regulators backed off their most aggressive fee proposals while litigation continues over smokable hemp restrictions. Rules that shift faster than businesses can price them tend to benefit larger players and push consumers toward less accountable channels. (Houston Chronicle)
Connecticut's House advanced a bill that would remove THC concentration limits on flower and concentrates, raise infused beverage limits from 3 milligrams to 5 milligrams, allow up to 10 milligrams in drinks sold through dispensaries or retailers, and open the door to topicals, tablets, and capsules. Rep. Roland Lemar framed it as a competitiveness fix aimed at licensed operators losing ground to neighboring states and illicit channels. Public health advocates warned about youth access, psychosis risk, and normalization outpacing treatment capacity. Connecticut is moving from scarcity-era guardrails toward regulated market realism, wagering that enforcement against illegal channels matters more than holding the licensed market below regional norms. (CT Mirror)
Sens. Ted Budd and Pete Ricketts introduced legislation requiring HHS to report to Congress on Medicaid spending tied to inpatient, outpatient, and emergency room services related to marijuana use. This is a SAM-style play: mislead, conflate, oppose. Even so, the response from legalization supporters should be data, not defensiveness. If a regulated cannabis market is working, regulators and industry should want the receipts out in public. Patients served. Jobs created. Taxes generated. Dollars spent on education about safe use, storage, and impaired driving. Harm-reduction outcomes tracked over time. The bills like this one will keep coming, and the only durable response is a record that can withstand scrutiny. Fight fire with fire, with better data. (Marijuana Moment)
Hakeem Jeffries told reporters this week that House Democrats have the votes to pass federal marijuana reform if Republican leadership would allow a floor vote. Fine, but the receipts are thin. Democrats held the House, the Senate, and the White House as recently as 2022 and did not pass SAFE Banking, did not reschedule, did not legalize, and did not send a clean federal bill to the president's desk. A 4/20 whip claim in the minority is cheap talk unless it is followed by campaign commitments, floor strategy, and kept promises when power returns. Cannabis voters are increasingly political free agents who reward whoever actually delivers, and neither party has earned durable loyalty. Jeffries has an opportunity here. Running on the issue, writing it into the platform, and passing it in the first hundred days of a Democratic trifecta would prove the point. Pointing at Republican leadership on 4/20 does not. (Marijuana Moment)
🏛️ Wisconsin's neighboring states have legalized. Michigan sells recreationally. Illinois sells recreationally and just put $31.8 million behind its equity program. Minnesota is building its market. Wisconsin is not. Republican legislative control continues to block movement, even as public support grows, consumer dollars cross state lines, and the federal hemp rewrite threatens one of the few remaining cannabinoid channels Wisconsin retailers have. Drift from a position of surrounded is harder to defend than drift from isolation. (The Center Square)
California's licensed cultivators remain squeezed between permitting drag, fixed Proposition 64 taxes, and an illicit market the state has not displaced. This is not a story that resolves quickly. California is the largest cannabis economy in the country by almost any measure, and the structural imbalances - tax burden, permitting cost, enforcement capacity, sheer market scale - mean even sustained good-faith policy work produces slow, partial progress. The most capable regulators and most thoughtful legislators in the country would still face a generational project here. That is worth remembering before attributing every California stumble to indifference or failure. Some problems are just that big. (CBS San Francisco)
Jarred Shaw, a 35-year-old American basketball player from Dallas and former Oklahoma State and Utah State forward, was sentenced in December to 26 months in an Indonesian prison after being arrested last May for receiving 132 cannabis gummies at his apartment. Shaw has Crohn's disease and was using cannabis, legally obtained during Indonesian Basketball League offseasons he spent in Thailand, to manage symptoms. He has lost roughly 40 pounds, tested positive for E. coli, and is held in a cell the size of a New York studio apartment with 11 other inmates. The death penalty was on the table before he was convicted on the lesser charge of possession. Willy Vlasic, through the Vlasic Classic Foundation, has been one of Shaw's most vocal advocates for compassionate release; Vlasic was our most recent guest on The Hybrid podcast, where he walked through this case and the broader work of advocating for non-violent cannabis prisoners abroad. U.S. cannabis normalization has moved faster than American travelers' understanding of international exposure, and countries with zero-tolerance regimes are not adjusting. The law does not travel with the consumer. The consequences do. (Reuters; The Hybrid podcast)




